BZO-4en-POXIZID is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC). Closely related analogue BZO-HEXOXIZID (MDA 19) was synthesized and studied in the late 2000’s by scientists at the University of Texas M. D. Anderson Cancer Center.
cfsre NPS Report (5/19/2022) To date, multiple OXIZID analogues have been identified worldwide, most of which are unstudied with pharmacological and human effects undetermined. Currently, no analogues of the OXIZID subclass are scheduled substances in the United States.
March of 2022 – CBP officers seized a shipment of BZO-4en-POXIZID, also known as 4en-pentyl MDA-19, and ADB-FUBIATA, also known as AD-18, on Feb. 11 at Washington Dulles International Airport. Although CBP officers have found similar MDA-19 compounds at other U.S. ports of entry, this is the first time the agency has encountered the 4en-pentyl variant.
November of 2023 – Five cases of unintentional exposure to BZO-4en-POXIZID among nightclub attendees in New York City